Logo image of ASA

ASA GOLD AND PRECIOUS METALS (ASA) Stock Price, Quote, News and Overview

NYSE:ASA - New York Stock Exchange, Inc. - BMG3156P1032 - Currency: USD

25.79  +0.44 (+1.74%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ASA. ASA was compared to 0 industry peers in the Unkown industry. ASA has a great financial health rating, but its profitability evaluates not so good. ASA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ASA had positive earnings in the past year.
ASA had positive earnings in 4 of the past 5 years.
In multiple years ASA reported negative operating cash flow during the last 5 years.
ASA Yearly Net Income VS EBIT VS OCF VS FCFASA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 0.56%
ROE 0.56%
ROIC N/A
ROA(3y)-13.7%
ROA(5y)5.84%
ROE(3y)-13.73%
ROE(5y)5.85%
ROIC(3y)N/A
ROIC(5y)N/A
ASA Yearly ROA, ROE, ROICASA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

ASA's Profit Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of ASA has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 58.5%
GM 93.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-68.83%
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y24.22%
ASA Yearly Profit, Operating, Gross MarginsASA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K -5K 10K

More info and screens

7

2. Health

2.1 Basic Checks

ASA has about the same amout of shares outstanding than it did 1 year ago.
ASA has about the same amout of shares outstanding than it did 5 years ago.
ASA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ASA Yearly Shares OutstandingASA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ASA Yearly Total Debt VS Total AssetsASA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ASA has an Altman-Z score of 417.91. This indicates that ASA is financially healthy and has little risk of bankruptcy at the moment.
ASA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 417.91
ROIC/WACCN/A
WACCN/A
ASA Yearly LT Debt VS Equity VS FCFASA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

ASA has a Current Ratio of 25.79. This indicates that ASA is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 25.79 indicates that ASA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 25.79
Quick Ratio 25.79
ASA Yearly Current Assets VS Current LiabilitesASA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 106.24% over the past year.
The earnings per share for ASA have been decreasing by -62.08% on average. This is quite bad
ASA shows a decrease in Revenue. In the last year, the revenue decreased by -6.09%.
ASA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.13% yearly.
EPS 1Y (TTM)106.24%
EPS 3Y-62.08%
EPS 5YN/A
EPS Q2Q%84.69%
Revenue 1Y (TTM)-6.09%
Revenue growth 3Y21.65%
Revenue growth 5Y8.13%
Sales Q2Q%-0.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASA Yearly Revenue VS EstimatesASA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
ASA Yearly EPS VS EstimatesASA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 257.90, ASA can be considered very expensive at the moment.
ASA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 257.9
Fwd PE N/A
ASA Price Earnings VS Forward Price EarningsASA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASA Per share dataASA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

ASA has a yearly dividend return of 0.16%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.33, ASA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.16%

5.2 History

The dividend of ASA decreases each year by -12.99%.
ASA has been paying a dividend for at least 10 years, so it has a reliable track record.
ASA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-12.99%
Div Incr Years1
Div Non Decr Years5
ASA Yearly Dividends per shareASA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ASA Yearly Income VS Free CF VS DividendASA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M

More info and screens

ASA GOLD AND PRECIOUS METALS

NYSE:ASA (3/7/2025, 8:05:41 PM)

25.79

+0.44 (+1.74%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)01-27 2025-01-27
Earnings (Next)07-21 2025-07-21
Inst Owners62.29%
Inst Owner Change4%
Ins Owners1.74%
Ins Owner Change51.71%
Market Cap490.53M
Analysts0
Price TargetN/A
Short Float %0.23%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield 0.16%
Yearly Dividend0.02
Dividend Growth(5Y)-12.99%
DP0%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 257.9
Fwd PE N/A
P/S 151.78
P/FCF N/A
P/OCF N/A
P/B 1.46
P/tB 1.46
EV/EBITDA N/A
EPS(TTM)0.1
EY0.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.17
BVpS17.61
TBVpS17.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 0.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 58.5%
GM 93.72%
FCFM N/A
ROA(3y)-13.7%
ROA(5y)5.84%
ROE(3y)-13.73%
ROE(5y)5.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-68.83%
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y24.22%
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 25.79
Quick Ratio 25.79
Altman-Z 417.91
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.24%
EPS 3Y-62.08%
EPS 5YN/A
EPS Q2Q%84.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.09%
Revenue growth 3Y21.65%
Revenue growth 5Y8.13%
Sales Q2Q%-0.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A